Ulrike Nowak-Göttl Selected Research

Protein S

1/2021	Two Novel Variants in the Protein S Gene PROS1 Are Associated with Protein S Deficiency and Thrombophilia.
1/2018	Thrombophilia testing in children: What and when should be tested?
1/2017	Inherited Thrombophilia in Pediatric Venous Thromboembolic Disease: Why and Who to Test.
1/2017	Risk factors for symptomatic venous and arterial thromboembolism in newborns, children and adolescents - What did we learn within the last 20years?
11/2016	Impact of high risk thrombophilia status on recurrence among children and adults with VTE: An observational multicenter cohort study.
10/2016	Impact of high-risk thrombophilia status on recurrence among children with a first non-central-venous-catheter-associated VTE: an observational multicentre cohort study.
9/2012	Venous thromboembolism in neonates and children.
8/2012	Inherited thrombophilia in children with venous thromboembolism and the familial risk of thromboembolism: an observational study.
5/2005	Lipoprotein (a) and other prothrombotic risk factors in Caucasian women with unexplained recurrent miscarriage. Results of a multicentre case-control study.
6/2004	Thrombosis in children with hematologic malignancies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ulrike Nowak-Göttl Research Topics

Disease

26	Thrombosis (Thrombus) 01/2020 - 01/2002
17	Hemorrhage 07/2022 - 09/2002
15	Thrombophilia 01/2022 - 09/2002
14	Stroke (Strokes) 01/2020 - 11/2002
11	Thromboembolism 10/2011 - 09/2002
10	Venous Thromboembolism 02/2021 - 05/2002
8	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018 - 06/2004
7	Hemophilia A (Haemophilia) 07/2022 - 02/2002
7	Protein S Deficiency (Deficiency, Protein S) 01/2021 - 01/2002
6	Ischemic Stroke 12/2014 - 11/2002
5	Protein C Deficiency 02/2014 - 09/2002
3	Pulmonary Embolism 11/2016 - 01/2002
3	Heart Diseases (Heart Disease) 01/2013 - 04/2003
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2010 - 04/2003
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 05/2022 - 01/2020
2	von Willebrand Diseases (von Willebrand's Disease) 11/2019 - 04/2011
2	Obesity 01/2014 - 05/2005
2	Atherosclerosis 01/2013 - 10/2011
2	Blood Vessel Dissection 08/2003 - 01/2003
2	Embolic Stroke 08/2003 - 01/2003
1	Pain (Aches) 07/2022
1	Hypersensitivity (Allergy) 07/2022
1	Cerebral Hemorrhage 05/2022
1	Atrial Fibrillation 05/2022
1	Heart Failure 03/2022
1	Delirium 03/2022
1	Acute Kidney Injury (Acute Renal Failure) 03/2022
1	Wounds and Injuries (Trauma) 11/2019
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Drug-Related Side Effects and Adverse Reactions 01/2018
1	Factor V Deficiency 01/2017
1	Inflammation (Inflammations) 08/2016
1	Infarction (Infarctions) 05/2016
1	Hypertension (High Blood Pressure) 01/2014
1	Vascular System Injuries 12/2012
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 09/2012
1	hereditary Thrombophilia 08/2012
1	Livedoid Vasculopathy 08/2010

Drug/Important Bio-Agent (IBA)

15	AntithrombinsIBA 01/2018 - 09/2002
14	Protein CIBA 01/2018 - 11/2002
13	Prothrombin (Factor II)IBA 02/2021 - 01/2002
13	Protein SIBA 01/2021 - 09/2002
12	factor V LeidenIBA 01/2017 - 09/2002
11	Lipoprotein(a)IBA 01/2013 - 01/2002
7	AnticoagulantsIBA 05/2022 - 09/2002
6	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2019 - 08/2003
6	Factor VIII (Coagulation Factor VIII)IBA 04/2011 - 09/2002
4	RivaroxabanIBA 01/2022 - 12/2016
4	Hemostatics (Antihemorrhagics)IBA 09/2019 - 09/2012
4	Factor V (Coagulation Factor V)IBA 01/2018 - 12/2003
4	Asparaginase (Elspar)FDA Link 06/2010 - 04/2003
3	AntibodiesIBA 07/2022 - 05/2005
3	Blood Group Antigens (Blood Groups)IBA 01/2022 - 01/2021
3	Metalloproteases (Metalloproteinases)IBA 01/2020 - 01/2013
3	ThrombospondinsIBA 01/2020 - 01/2013
3	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 01/2003
3	DisintegrinsIBA 01/2020 - 01/2013
3	von Willebrand FactorIBA 09/2019 - 01/2013
3	Antiphospholipid AntibodiesIBA 09/2012 - 04/2010
3	Fibrinogen (Factor I)FDA Link 08/2009 - 09/2002
3	HomocysteineIBA 06/2004 - 09/2002
2	Vitamin K FDA Link 05/2022 - 10/2019
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2021 - 06/2008
2	Oral ContraceptivesIBA 01/2014 - 11/2002
2	Pharmaceutical PreparationsIBA 02/2012 - 01/2003
2	ORALIT (ORS)IBA 10/2011 - 04/2010
2	SteroidsIBA 06/2010 - 04/2003
2	Enoxaparin (Lovenox)FDA LinkGeneric 06/2010 - 12/2006
2	Prednisone (Sone)FDA LinkGeneric 03/2009 - 04/2003
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2003 - 01/2003
2	Thrombin FDA Link 06/2003 - 04/2003
1	BESIBA 07/2022
1	recombinant FVIIa (rFVIIa)FDA Link 07/2022
1	Factor VII (Proconvertin)IBA 07/2022
1	apixabanIBA 01/2022
1	Tranexamic Acid (AMCA)FDA Link 01/2020
1	P-2 (P 2)IBA 01/2020
1	Fondaparinux (Arixtra)FDA Link 10/2019
1	Heparin (Liquaemin)FDA LinkGeneric 01/2018
1	vinyltriethoxysilane (VTES)IBA 11/2016
1	TESIBA 05/2016
1	Biomarkers (Surrogate Marker)IBA 12/2014
1	ADAMTS13 ProteinIBA 01/2013
1	ADAMTS ProteinsIBA 12/2012
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2012
1	histidine-rich proteinsIBA 06/2010
1	Testosterone (Sustanon)FDA Link 12/2009
1	Protein Isoforms (Isoforms)IBA 08/2009
1	fibrinogen gamma'IBA 08/2009

Therapy/Procedure

15	Therapeutics 05/2022 - 01/2002
4	Catheters 10/2019 - 02/2002
2	Extracorporeal Membrane Oxygenation 01/2021 - 04/2003
2	Central Venous Catheters 01/2017 - 10/2016
2	Kidney Transplantation 05/2016 - 01/2003
2	Secondary Prevention 08/2003 - 01/2003
1	Palliative Care (Palliative Therapy) 05/2022
1	Heart-Assist Devices 03/2022
1	Platelet Transfusion (Blood Platelet Transfusions) 03/2022
1	Deep Brain Stimulation 01/2020
1	Renal Dialysis (Hemodialysis) 05/2016